EICHORPublic-registry site landscape for NCT05641896, “Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers”, a Gastrointestinal Cancers study sponsored by SOFIE. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05641896 (registry record) |
| Study title | Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers |
| Official title | A Phase 2, Multicenter, Single Arm, Open Label, Non-Randomized Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers |
| Sponsor | SOFIE |
| Condition(s) | Gastrointestinal Cancers; Cholangiocarcinoma; Gastric Cancer; Colorectal Cancer |
| Phase | PHASE2 |
| Listed sites | 6 |
| Intervention(s) | [18F]FAPI-74 PET/CT |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05641896.
Eichor generates a preliminary site-risk snapshot for NCT05641896 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Gastrointestinal Cancers trials
← Eichor home · All tracked trials · Gastrointestinal Cancers studies · Weekly briefs
